Trial Profile
A Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (Itraconazole) Ointment, 5% in Patients With Inflammatory Lesions of Rosacea Over 12 Weeks
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2019
Price :
$35
*
At a glance
- Drugs Itraconazole (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 22 Feb 2018 Status changed from active, no longer recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 05 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.